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Keratin K6 is known as an in¯ammatory and hyper-
proliferative keratin, and is induced by an in¯amma-
tory and hyperproliferative agent. In this study, we
demonstrated that interferon-g, an antiproliferative
agent, also induces keratin K6. We used normal
human ex vivo skin, normal human cultured kera-
tinocytes, HaCaT keratinocytes, and DJM cells to
examine the induction of K6 by interferon-g, by
immunohistochemical staining, Western blot analy-
sis, promoter chloramphenicol acetyl transferase
assay, and reverse transcriptase polymerase chain
reaction of mRNA. We succeeded in demonstrating
the induction of keratin K6 by interferon-g in ex vivo
human skin and HaCaT keratinocytes at the protein
and message level, and in cultured normal human
keratinocytes at the promoter level. The inhibition
of the signal transducing activator of transcription 1
pathway by a dominant-negative transfer gene
caused the inhibition of K6 induction by interferon-
g, and the blocking of nuclear factor kB using anti-
sense oligonucleotides also inhibited the K6 induc-
tion. We also blocked the released interleukin-1a
from keratinocytes after stimulation with interferon-
g by neutralizing antibodies, which showed a
decrease in the K6 induction. Our results suggest
that a small amount of interleukin-1a, which cannot
induce K6 by itself, is secreted upon stimulation by
interferon-g, and that the induction of K6 occurs
through the synergistic effect of the interferon-g/sig-
nal transducing activator of transcription 1 and inter-
leukin-1a/nuclear factor kB pathways. This is the
®rst report to describe K6 induction in epidermal
keratinocytes by interferon-g and indicate a probable
signal transduction pathway, and demonstrates that
K6 is a possible partner of K17 in the in¯ammatory
process. Key words: ex vivo/STAT1/NFkB. J Invest
Dermatol 119:403±410, 2002
I
n¯ammation in skin changes the phenotypes of keratinocytes
to express various in¯ammatory proteins, which do not exist
in normal skin. In normal human epidermal keratinocytes,
keratins K5 and K14 are expressed in the basal layer, and K1
and K10 are expressed in the differentiating suprabasal layers
(Fuchs and Green, 1980; Moll et al, 1982). In in¯amed epidermis,
however, K6, K16, and K17, which are not expressed in healthy
interfollicular epidermis, are expressed in the suprabasal inter-
follicular epidermis (Weiss et al, 1984; Navarro et al, 1995;
Blumenberg and Tomic-Canic, 1997). In in¯ammatory or hyper-
proliferative skin diseases such as psoriasis vulgaris and atopic
dermatitis, these in¯ammatory keratins are expressed suprabasally,
and thus they have been studied in relation to these skin diseases
(Leigh et al, 1995). Recently, some of the in¯ammatory cytokines
have been reported to induce these in¯ammatory keratins, i.e.,
tumor necrosis factor a (TNF-a) induces K6 (Komine et al, 2000),
epidermal growth factor (EGF) and transforming growth factor a
(TGF-a) induce both K6 and K16 (Jiang et al, 1993), interleukin-1
(IL-1) induces K6, K16 (Komine et al, 2001), and K17 (Wei et al,
1999), and interferon-g (IFN-g) induces K17 (Bonnekoh et al,
1995; Vogel et al, 1995; Milisavljevic et al, 1996; Wei et al, 1999).
IFN-g is one of the key factors in in¯ammatory skin diseases,
which mediates Th-1 type in¯ammation and growth inhibition of
keratinocytes. IFN-g is known to exist in the epidermis in psoriasis
and subcutaneous injection of IFN-g induces psoriatic plaques in
psoriasis patients (Fierlbeck et al, 1990). According to the previous
reports, IFN-g induces only keratin K17 through the activation of
signal transducing activator of transcription (STAT) 1 (Jiang et al,
1994), and/or K16 (Wei et al, 1999). It is well known that keratin
intermediate ®laments are constituted with heterodimers contain-
ing both type I and type II keratins (Fuchs and Albers, 1994). The
counterpart of keratin K17 induced by IFN-g is unknown,
however. We speculated that keratin K6, an in¯ammatory type II
keratin, might be induced by IFN-g together with keratin K17 to
form heterodimers.
K6, together with K16 and K17, are known as proliferation
associated keratins, because they are found in the hyperproliferative
epidermis in in¯ammatory skin diseases such as psoriasis, atopic
dermatitis, and eczema. They are also found in the atrophic
epidermis, however, and in necrotic and apoptotic keratinocytes as
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seen in graft versus host disease, lichen planus, and sunburned skin.
Although K6 is thought to be related to the hyperproliferative state
of the epidermis, its induction pathways are not always involved in
hyperproliferative signals, as we have shown previously in that K6
induction by TNF-a occurs through a distinct pathway from that
by EGF (Komine et al, 2000). We demonstrated here that IFN-g, a
strong suppressor of cell proliferation, induces K6, and that its
induction is independent of other known pathways that induce K6.
MATERIALS AND METHODS
DNA constructs The plasmids containing K6 promoter connected to
the chloramphenicol acetyl transferase (CAT) gene (K6pgCAT) and the
control plasmid pRSVZ were discussed in previous papers (Jiang et al,
1991; Komine et al, 2001) and were generous gifts from Dr. Miroslav
Blumenberg (New York University Medical Center, NY).
Cell culture Primary culture of normal human neonatal foreskin
keratinocytes (NHK) were obtained from IWAKI Glass (Tokyo, Japan)
and grown routinely in keratinocyte medium with bovine pituitary
extract (20±30 mg per ml) and EGF (0.1±0.2 ng per ml) (Gibco BRL,
MD). At 70%±80% con¯uency, the cells were trypsinized and expanded
at a 1:4 ratio. At three or four passages, the subcon¯uent cells were
transfected and/or stimulated with IFN-g for further investigation.
HaCaT keratinocytes were generous gifts from Professor N. Fusenig
(Institute fuÈr Zell- und Tumorbiologie, Deutsches Kresforschungs-
zentrum, Heidelberg, Germany) and were grown routinely in modi®ed
Eagle's medium (MEM; Sigma, MO) supplemented with 10% fetal
bovine serum (FBS). DJM cells were generous gifts from Professor
Kitajima (Gifu University, Gifu, Japan), and were grown routinely in
MEM with 10% FBS. They were incubated in a humidi®ed incubator
with 5% CO2 at 37°C. The cells were exposed to IFN-g (recombinant
human IFN-g; R&D Systems, MN), at concentrations of 30, 100, 300,
or 1000 U per ml. 0.1 mg per ml of anti-IL-1a neutralizing antibody
(anti-human IL-1a neutralizing antibody; R&D Systems) was added to
examine the effect of IL-1. The cells and supernatant were harvested
after 6±80 h of incubation.
Normal human skin (NHS) for ex vivo system NHS samples were
obtained after informed consent from patients and laboratory volunteers
in accordance with the Declaration of Helsinki. These samples were cut
in 5 3 5 3 5 mm sections and incubated with or without IFN-g at
concentrations of 30, 100, 300, or 1000 U per ml in keratinocyte basal
medium [keratinocyte serum-free medium without bovine pituitary
extract, EGF, insulin, hydrocortisone, or thyroid hormone (KBM),
Gibco BRL] with 100 U per ml penicillin (Gibco BRL), 100 mg per ml
streptomycin (Gibco BRL), and 0.25 mg per ml amphotericin B (Gibco
BRL) using a Transwell culture system (Netwell, Costar, Cambridge,
MA) for 8, 16, 24, or 48 h. In the case of mRNA analysis, incubations
were performed with 25 U per ml ribonuclease inhibitor (Takara Shuzo,
Shiga, Japan). For immunohistochemical staining, the cultured samples
were embedded in OCT compound (Sakura Finetechnical, Tokyo,
Japan) and frozen with liquid nitrogen immediately after incubation. For
both mRNA and Western analysis, the cultured samples were frozen
with liquid nitrogen and stored at ±80°C until use.
Immunohistochemical staining NHS ex vivo samples treated with or
without IFN-g (100 U per ml) embedded in OCT compound were cut
in 6 mm thick sections, air-dried, acetone-®xed, and incubated with
monoclonal antihuman keratin antibodies (Table I) overnight at 4°C,
followed by staining with an avidin±biotin complex peroxidase technique
(Becton Dickinson, CA). The stained samples were mounted and
examined under a light microscope (Nikon, Tokyo, Japan).
Recombinant adenovirus Adenovirus vectors containing the genes
for HA-tagged wild-type STAT1 (AxCAwtSTAT1) and HA-tagged
dominant-negative STAT1 (AxCAdnSTAT1) (Nakajima et al, 1996),
which contain a CAG promoter (chicken b-actin promoter with
cytomegalovirus enhancer), were prepared by homologous recombin-
ation in 293 cells as described previously (Hanakawa et al, 2000). DNA
encoding wtSTAT1 and dnSTAT1 were kind gifts from Dr. Nakajima
of Osaka City University. The viral preparations were titrated with a
plaque-forming assay on 293 cells. HaCaT cells were infected with
AxCAwtSTAT1 or AxCAdnSTAT1 at a multiplicity of infection of 5 in
MEM containing 10% FBS. After 24 h infection with adenovirus
vectors, HaCaT cells were incubated with or without 100±1000 U per
ml of IFN-g for 24 h. The cells were harvested by scraping with
phosphate-buffered saline and the inductions of K6 and K17 were
examined by Western blotting or employed for cell count.
Enzyme-linked immunosorbent assay (ELISA) Supernatant IL-1a
concentrations of HaCaT cells were measured when cultured with or
without IFN-g using Quantikine Human IL-1a Immunoassay (R&D
Systems). Brie¯y, 96-well plates precoated with anti-IL-1a antibody
were incubated with standards or samples for 2 h at room temperature,
followed by three washes, and then incubated for 2 h at room
temperature with IL-1a conjugate followed by an incubation with
substrate solution for 20 min at room temperature. The optical density of
each well was determined using a microplate reader (Model 550, Bio-
Rad, CA) set to 450 nm.
Antisense oligonucleotides for nuclear factor kB (NFkB) We
prepared antisense oligonucleotides for both NFkB (TGGATCATC-
TTCTGCCATTCT) and inhibitor of NFkB (IkB) (GCGCTCGGC-
CGCCTGGAACATGGC) in phosphorothioate form as described in a
previous paper (Komine et al, 2000). These antisense oligonucleotides
were shown to inhibit NFkB and IkB production, respectively, in
keratinocytes (Nestle et al, 1994). We incubated 30%±50% con¯uent
HaCaT cells with antisense or sense oligonucleotides at 15 mg per 10 cm
diameter Petri dish for 24 h and then added IFN-g at concentrations of
100±1000 U per ml with the same type of oligonucleotides for NFkB at
15 mg per dish simultaneously. Twenty-four hours later, we harvested
the cells by scraping as described above and examined the K6 induction
by Western blotting.
Cell counts After the incubation with or without 100 U per ml of
IFN-g, the cells were trypsinized with 0.5 ml per dish of 0.05% trypsin.
The trypsinized cells were harvested, and reconstituted with 9.5 ml of
Isoton (Beckman Coulter, Tokyo, Japan). The numbers of HaCaT
keratinocytes, DJM cells, and NHK were counted using Coulter Z1
(Coulter Electronics, Bedfordshire, U.K.).
Keratin extraction and Western blot analysis Ex vivo skin samples,
NHK, HaCaT keratinocytes, and DJM cells treated with or without
IFN-g (100±1000 U per ml) were disrupted in 25 mM Tris/5%
ethylenediamine tetraacetic acid/1% ethyleneglycol-bis(b-aminoethyl
ether)-N,N,N¢,N¢-tetraacetic acid/1.5 M KCl±Triton X-100 (pH 7.5)
with 2 mM phenylmethylsulfonyl ¯uoride (Boehringer Mannheim, IN),
and the keratins were extracted using 9.5 M urea in 25 mM Tris
(pH 7.5) as previously described (Eichner and Kahn, 1990). The
concentrations of the extracted proteins were measured using a BCA
Protein Assay Kit (Pierce, IL). The extracted keratins were boiled in
sample buffer [50 mM Tris (pH 7.4)/0.14% sodium dodecyl sulfate
(SDS)/1% b-mercaptoethanol (vol/vol)], and separated by 12.5% SDS
polyacrylamide gel electrophoresis (10 mg protein per lane). After transfer
to an Immobilon-P transfer membrane (Millipore, MA), the membrane
was incubated in blocking buffer [5% bovine serum albumin in 25 mM
Tris/0.02% KCl/0.8% NaCl (pH 7.4)] for 2±8 h at 4°C, followed by
incubation with monoclonal antihuman keratin antibodies (Table I)
overnight at 4°C. The membrane was washed and incubated with a
secondary antibody for 1 h, and the bands were visualized by a
chemiluminescence method (Phototope-HRP Western Blot Detection
Kit, New England BioLabs, MA). The densities of the bands were
scanned by Canoscan FB1200S (Canon, Tokyo, Japan) for densitometric
analysis and semiquantitated using the NIH Image 1.49 software.
Table I. Monoclonal antibodies
For
immunohisto-
chemistry
For Western
blotting
Keratin K1 34bB4 Enzo 1:10 NDa
Keratin K5 C-50 sanbio 1:10 ND
Keratin K6 Ks6.KA12 Progen 1:100 1:200
Keratin K8 c-43 sanbio 1:10 ND
Keratin K10 DE-K10 sanbio 1:100 1:1000
Keratin K14 LL002 NeoMarkers 1:100 1:1000
Keratin K17 Ks17.E3 Progen 1:100 1:200
Keratin K18 DC-10 sanbio 1:10 ND
STAT1a p91 C-111 Santa Cruz 1:200 ND
aND, not done.
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Promoter analysis At 70%±80% con¯uency, cells in 60 mm diameter
dishes were transfected with 10 mg K6-CAT and 2 mg RSVZ constructs.
After 5±6 h of incubation with the constructs in 10 ng per ml polybrene,
the cells were shocked with 27% dimethylsulfoxide as described
previously (Jiang et al, 1991). The cells were then incubated in KBM
with or without IFN-g at concentrations of 30, 100, 300, and 1000 U
per ml. After 24 h of incubation, the cells were harvested by scraping
with phosphate-buffered saline, and disrupted by repeated freeze±thaw
cycles. A CAT assay was performed using a CAT assay kit (Amersham
Pharmacia Biotech, Tokyo, Japan), and a b-galactosidase assay was
performed as described previously (Jiang et al, 1991). All CAT values
were normalized for transfection ef®ciency by calculating the ratio of
CAT activity to b-galactosidase in each transfected plate.
Reverse transcriptase polymerase chain reaction (RT-PCR) RNAs
were extracted from IFN-g-treated NHS using an RNA mini kit (Qiagen,
Hilden, Germany). The extracted RNA samples were reverse transcribed,
and the cDNA were ampli®ed using the primers for K6 (forward,
GAGATCGACCACGTCAAGAAGC; reverse, TGACTTGTCCAA-
CGCCTTTCG) using an Access RT-PCR System (Promega, WI). The
reaction mix containing the extracted RNAs and primers was heated to
48°C and incubated for 45 min for reverse transcription, then heated to
94°C for 2 min to inactivate reverse transcriptase and RNA/cDNA/
primer. Then, 30 cycles of denaturation (94°C for 30 s), annealing (60°C
for 1 min), and extension (68°C for 2 min) were carried out, followed by
a ®nal extension of 68°C for 7 min. The reaction products were analyzed
by 2% agarose gel electrophoresis.
RESULTS
Keratin K6 expression was induced suprabasally by IFN-g in
normal human ex vivo skin The ex vivo skin system is an
excellent tool to detect in¯ammatory keratin induction by
cytokines and growth factors (Komine et al, 2000, 2001). We
used the ex vivo skin system to examine the induction of K6
expression in keratinocytes at the protein level. The ex vivo skin
samples incubated in KBM for up to 48 h showed similar keratin
expression patterns as the normal skin samples before incubation.
The immunohistochemical staining of monoclonal keratin
antibodies of NHS incubated ex vivo for 8±48 h without IFN-g
revealed that the keratins K5/14 were detected in the basal and
lower part of the suprabasal layers, K1/10 were detected
throughout the malpighian stratum, K6 (Fig 1A) and K17 were
detected in the sweat gland epithelia, and K17 was also detected in
the outer root sheath of the hair follicles. K8/18 were not detected
throughout the epidermis. These results are consistent with
previous reports of normal keratin expressions (Komine et al,
2000, 2001). On the other hand, the ex vivo skin samples incubated
with IFN-g at a concentration of more than 100 U per ml showed
expression of K6 (Fig 1B) and K17 suprabasally in addition to the
sweat gland epithelia and the hair follicles. The expression patterns
of K1, K5, K8, K10, K14, and K18 did not change, however, with
the stimulation by IFN-g.
K6induction by IFN-g was con®rmed by Western blot
analysis Next, we showed the keratin inductions semi-
quantitatively using Western blot analysis. Insoluble keratin
fractions extracted from the ex vivo skin samples, HaCaT
keratinocytes, DJM cells, and NHK incubated with or without
IFN-g were analyzed using Western blot analysis. As for ex vivo
skin, the density of the bands for keratins K1 and K10 was revealed
to be almost the same between the lanes of the extracts from those
treated with and without IFN-g. Keratins K6 and K17, however,
were induced in ex vivo skin incubated with IFN-g in a dose-
dependent manner at concentrations of 100±1000 U per ml
(Fig 2). Keratins K1 and K10 were not expressed in HaCaT
keratinocytes in our experimental environment. Constitutive
expression of keratins K6 (Fig 2) and K17 (data not shown) were
enhanced by IFN-g in HaCaT keratinocytes in a dose-dependent
manner at the concentrations of 100±1000 U per ml. DJM cells
incubated with IFN-g contained almost the same amounts of
keratins K6 (Fig 2) and K17 (data not shown), however, as those of
DJM cells incubated without IFN-g. We also examined the keratin
extracts from NHK incubated with or without IFN-g.
In¯ammatory keratins such as K6, K16, and K17 were already
highly expressed in NHK, which is consistent with our previous
paper (Komine et al, 2000, 2001). Therefore, the expression of
keratin K6 in NHK was only slightly increased when incubated
with IFN-g.
The bands for keratin K6 and b-actin as a control were measured
using NIH Image, and the fold inductions normalized against
b-actin were calculated. The fold inductions of K6 in NHS were
2.81 6 0.8 (p < 0.001) with 100 U per ml of IFN-g, and those in
HaCaT kertinocytes were 1.58 6 0.54 (p < 0.01) with 100 U per
ml of IFN-g, 1.73 6 0.53 (p < 0.01) with 300 U per ml of IFN-g,
and 2.50 6 1.33 (p < 0.05) with 1000 U per ml of IFN-g, which
showed that the inductions of K6 by IFN-g in both NHS and
HaCaT keratinocytes were almost dose-dependent through
1000 U per ml, and were statistically signi®cant (p < 0.05)
(Fig 3), whereas b-actin stayed at almost the same level.
The results by Western blot analysis of the keratin inductions by
IFN-g in ex vivo skin samples were consistent with those by
Figure 1. Keratin K6 was induced in ex vivo skin by stimulation
of IFN-g. The immunohistochemical staining with monoclonal keratin
antibodies of NHS incubated ex vivo without IFN-g (A) revealed that
keratin K6 was not detected throughout the interfollicular epidermis.
The ex vivo skin samples incubated with IFN-g at a concentration of
100 U per ml (B) showed the expression of K6 suprabasally in addition
to the sweat gland epithelia. Scale bars: (A) 20 mm, (B) 50 mm.
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immunohistochemical staining, and the results by Western blot
analysis of K6 and K17 inductions in HaCaT keratinocytes were in
accordance with those in ex vivo skin samples.
IFN-g suppressed proliferation of HaCaT keratinocytes,
DJM cells, and NHK To examine the in¯uence of IFN-g on
each keratinocyte cell line, the growth inhibition by IFN-g
(Saunders and Jetten, 1994) was assayed by counting the numbers
of HaCaT keratinocytes, DJM cells, and NHK. Proliferation of all
the cell types examined was inhibited by addition of IFN-g at a
concentration of 100 U per ml (Fig 4A). Further, to investigate if
STAT1 is involved in growth inhibition by IFN-g, we also
examined the growth inhibition of HaCaT keratinocytes by IFN-g
when infected with adenovirus containing AxCAdnSTAT1 or
AxCAwtSTAT1. The increased rate in cell numbers of HaCaT
keratinocytes infected with AxCAdnSTAT1 was not inhibited by
IFN-g treatment (Fig 4B), whereas that of HaCaT keratinocytes
infected with AxCAwtSTAT1 was inhibited by IFN-g. Our data
suggested that the growth inhibition also occurred through STAT1
in HaCaT keratinocytes, which is reported in other cell lines (Chin
et al, 1996).
The inductions of keratins K6 and K17 were inhibited by the
infection of adenovirus vector encoding STAT1 dominant-
negative gene To examine whether the induction of K6
expression in keratinocytes was through the STAT1 pathway, we
infected HaCaT keratinocytes with adenovirus vector encoding
the STAT1 dominant-negative gene. The blocking of the
STAT1 pathway by the STAT1 dominant-negative genes
(AxCAdnSTAT1) inhibited the K6 induction by IFN-g in
HaCaT keratinocytes (Fig 5A). The densities of the bands of
Western blot analysis were scanned and semiquantitated as
described above. The fold induction of K6 in HaCaT
keratinocytes with wild-type gene was 2.04 6 0.84 with 1000 U
per ml of IFN-g, and with AxCAwtSTAT1 was 0.93 6 0.18 (p
< 0.001) (Fig 5B). As the induction of keratin K17 in keratinocytes
by IFN-g was reported to be through STAT1 proteins (Jiang et al,
1994; Komine et al, 1996), we also examined the K17 induction by
IFN-g in HaCaT keratinocytes infected with the AxCAwtSTAT1.
The induction of K17 expression in HaCaT keratinocytes was also
inhibited (Fig 5A).
The induction of keratin K6 by IFN-g was inhibited by the
blocking of secreted IL-1a from keratinocytes Both NHK
and HaCaT keratinocytes produce and secrete IL-1a, and IFN-g
induces IL-1a release from these keratinocytes (Maruyama et al,
1995; Phillips et al, 1995). Further, we have demonstrated
previously that IL-1a induces the induction of K6 expression in
NHK (Komine et al, 2001). Therefore, we veri®ed whether the
induction of keratin K6 expression was directly by IFN-g or
indirectly by IFN-g through IL-1a secreted from keratinocytes by
stimulation with IFN-g. First, we measured the supernatant
concentrations of IL-1a of HaCaT keratinocytes by ELISA,
which were increased up to 50 pg per ml by the incubation with
IFN-g in a dose-dependent manner at the concentrations of 30±
1000 U per ml (Fig 6A); these results are in accordance with the
previous reports (Maruyama et al, 1995; Phillips et al, 1995). Next
we incubated HaCaT keratinocytes with IFN-g after the blocking
of supernatant IL-1a by anti-IL-1a neutralizing antibody at
0.05 mg per ml and 0.1 mg per ml, which were considered to be
suf®cient for blocking the IL-1a activity secreted from HaCaT
keratinocytes stimulated by IFN-g. Although the secreted IL-1a
concentrations were too low to induce keratin K6 expression by
Figure 2. Western blot analysis of keratins in
ex vivo skin samples, HaCaT keratinocytes,
and DJM cells incubated with IFN-g. Keratin
K6 was induced in ex vivo skin and HaCaT
keratinocytes incubated with IFN-g in a dose-
dependent manner at concentrations of 100±
1000 U per ml. Keratin K10 stayed at almost the
same level by IFN-g treatment in ex vivo skin.
Keratin K10 was not expressed in either HaCaT
keratinocytes or DJM cells in our experimental
environment. DJM cells incubated with IFN-g
contained almost the same amounts of keratin K6
as those of DJM cells incubated without IFN-g.
Figure 3. Keratin K6 was signi®cantly induced by IFN-g both in
ex vivo skin and HaCaT keratinocytes. The fold induction indicates
the relative ratio of band intensity with IFN-g stimulation against that
without stimulation. The fold inductions of K6 by 100 U per ml and
300 U per ml of IFN-g in NHS, and those by 100 U per ml, 300 U per
ml and 1000 U per ml of IFN-g in HaCaT keratinocytes were dose-
dependent, and were statistically signi®cant. (*p < 0.05, **p < 0.01,
***p < 0.01).
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themselves (data not shown), the induction of K6 expression by
IFN-g was inhibited by the blocking of the supernatant IL-1a
(Fig 6B). The densities of the bands of Western blot analysis were
scanned and semiquantitated as described above. The fold
inductions of K6 in HaCaT keratinocytes without anti-IL-1a
antibody were 1.02 with 100 U per ml of IFN-g and 1.23 with
1000 U per ml of IFN-g, those with anti-IL-1a antibody of
0.05 mg per ml were 0.96 with 100 U per ml of IFN-g and 0.90
with 1000 U per ml of IFN-g, and those with anti-IL-1a antibody
of 0.1 mg per ml were 0.95 with 100 U per ml of IFN-g and 0.93
with 1000 U per ml of IFN-g (Fig 6C).
Antisense oligonucleotides for NFkB inhibited the induction
of K6 expression by IFN-g in HaCaT keratinocytes The
results that the blocking of secreted IL-1a from HaCaT
keratinocytes inhibited the K6 induction by IFN-g suggested that
the induction was not only through STAT1, but also through other
transcription factors such as C/EBP-b, AP-1, and NFkB, which are
usually activated by IL-1a. STAT1 and NFkB have been reported
to work synergistically in inducing interferon-regulatory factor 1
(IRF-1) and interferon-stimulated gene factor 2 (Ohmori et al,
1997; Pine, 1997). Because IL-1a secreted from keratinocytes by
IFN-g stimulation was too low to induce keratin K6 by itself, we
speculated that the secreted IL-1a worked synergistically in
inducing K6 with IFN-g. Hence, we blocked the pathway
through IL-1a using antisense oligonucleotides for NFkB. The
inductions of K6 expression by IFN-g in HaCaT keratinocytes
were inhibited by the incubations with antisense oligonucleotides
for NFkB, although the induction was not blocked with antisense
oligonucleotides for IkB (Fig 7).
Messenger RNA of keratin K6 was induced by IFN-g in
NHS To investigate the induction of K6 expression at the
mRNA level, we extracted total RNA from the normal human
skin ex vivo samples treated with or without IFN-g, and performed
RT-PCR using the primers for keratin K6. As the internal control,
we used glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA. As shown in Fig 8, the GAPDH mRNA levels did not
change in response to the IFN-g treatment. In contrast, the mRNA
of K6 increased in response to the IFN-g treatment.
Keratin K6 promoter was activated by IFN-g in NHK The
induction of K6 expression was clearly demonstrated above in both
NHS and HaCaT keratinocytes at the protein level; however, the
induction in NHK was very low at the protein level, because K6, as
an in¯ammatory keratin, is constitutively expressed in NHK
Figure 4. Proliferation of cells was inhibited by IFN-g, which was
reversed by the presence of dominant-negative STAT1. (A) The
numbers of cells are shown along the vertical line. Proliferation of all the
cell types examined was inhibited by addition of IFN-g at a
concentration of 100 U per ml. (B) The growth inhibition of HaCaT
keratinocytes by IFN-g when infected with adenovirus containing
AxCAwtSTAT1 or AxCAdnSTAT1 is shown. The relative increased
rate indicates the ratio of increased rate in cell numbers incubated with
IFN-g versus that without IFN-g, i.e., the relative increased rate = [(cell
numbers of 24 h incubation with IFN-g)/(cell numbers of 0 h
incubation with IFN-g)]/[(cell numbers of 24 h incubation without
IFN-g)/(cell numbers of 0 h incubation without IFN-g)]. The increased
rate in cell numbers of HaCaT keratinocytes infected with
AxCAdnSTAT1 was not inhibited by the IFN-g treatment. (*p < 0.05).
Figure 5. The inductions of both keratins K6 and K17 were
inhibited in HaCaT keratinocytes with the dominant-negative
STAT1 gene. (A) The blocking of the STAT1 pathway by
AxCAwtSTAT1 inhibited K6 and K17 induction by IFN-g in HaCaT
keratinocytes. (B) The densities of the bands of Western blot analysis
were scanned and semiquantitated. The fold induction of K6 in HaCaT
keratinocytes with AxCAdnSTAT1 was signi®cantly inhibited in
comparison with that with AxCAwtSTAT1.
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probably due to the culture medium containing a growth factor.
Thus, we investigated the K6 induction at the promoter level in
NHK. As the regulation of keratin K6 gene expression occurs at
least partly at the level of transcription, we transfected NHK with a
DNA construct that contains the K6 gene promoter driving the
CAT reporter and then incubated NHK with or without IFN-g.
The promoter activity of K6 increased with the incubation with
IFN-g at concentrations of 30 U per ml up to 300 U per ml in a
dose-dependent manner, and the induction of the K6 promoter
activity was almost the same when incubated with IFN-g at
concentrations over 300 U per ml (Fig 9). This induction occurred
only when the keratinocytes were subcon¯uent. When they were
con¯uent, IFN-g could not induce K6 promoter activity (data not
shown).
DISCUSSION
Keratins K6, K16, and/or K17 are known to be in¯ammatory
keratins, copious amounts of which are expressed in in¯ammatory
skin diseases such as psoriasis vulgaris. In these diseases, various
in¯ammatory cytokines are released from keratinocytes or in®l-
trated lymphocytes. Among them, IL-1a, EGF, and TGF-a were
reported to induce K6 and K16 (Jiang et al, 1993; Komine et al,
2001), which are probably expressed in forming heterodimers.
IFN-g was only demonstrated to induce K17 and/or K16
previously, however, and the counterpart of K17 was unknown
(Bonnekoh et al, 1995; Vogel et al, 1995; Milisavljevic et al, 1996;
Wei et al, 1999). Mutations in K6 and K17 lead to similar nail
abnormalities, giving a genetic indication that K6 and K17 pair. In
this study, we demonstrated that IFN-g induced keratin K6 in
normal human ex vivo skin, NHK, and HaCaT keratinocytes at the
protein level, mRNA level, and promoter level, which extended
the above ®nding by demonstrating that K6 and K17 pair in
in¯ammatory processes as well. We also demonstrated clearly that
IFN-g exhibits strong antiproliferative action on these cells. The
®ndings are very important also because, although K17 was known
before as a marker of in¯ammation, K6 was long associated with
the hyperproliferative state.
It is well known that in cultured keratinocytes large amounts of
in¯ammatory keratins are already expressed probably due to the
culture medium containing a growth factor. Therefore, we used
ex vivo skin to examine the induction of keratin K6 by IFN-g, the
usefulness of which has already been reported (Komine et al, 2000,
2001). Immunohistochemical study of ex vivo skin showed that K6
was expressed suprabasally throughout the epidermis by incubation
with IFN-g. Next, we showed the K6 induction semiquantitatively
by Western blotting. The results of Western blot analysis revealed
that not only ex vivo skin but also HaCaT keratinocytes showed a
signi®cant increase in K6 expression induced by IFN-g. We
considered that we could use HaCaT keratinocytes as an appro-
priate model of keratin K6 induction by IFN-g. On the other hand,
NHK only showed a slight increase in K6 expression by IFN-g,
probably due to the constitutive stimulation by a growth factor
contained in the culture medium, which induced K6. As for DJM
cells, we could not detect the induction of K6 by IFN-g, although
the growth arrest by IFN-g was clearly observed. It is possible that
K6 is already fully induced before the stimulation by IFN-g. We
considered this could be because of the difference in mechanisms of
Figure 6. The inductions of both K6 and K17 expressions were
inhibited by the blocking of IL-1a released from keratinocytes.
(A) The supernatant concentrations of IL-1a of HaCaT keratinocytes
were increased by incubation with IFN-g in a dose-dependent manner at
concentrations of 30±1000 U per ml. (B) The inductions of K6 and K17
expression by IFN-g in HaCaT keratinocytes were partially inhibited by
the blocking of the supernatant IL-1a secreted from keratinocytes by
preincubation with anti-IL-1a neutralizing antibody at 0.1 mg per ml.
(C) The densities of the bands of Western blot analysis were scanned and
semiquantitated. The fold induction of K6 by 1000 U per ml of IFN-g
in HaCaT keratinocytes with anti-IL-1a antibody was negligible
compared to that without anti-IL-1a antibody.
Figure 7. The blocking of the NFkB pathway abolished the
induction of K6 expression by IFN-g in HaCaT keratinocytes.
The induction of K6 expression by IFN-g in HaCaT keratinocytes was
blocked by incubation with antisense oligonucleotides for NFkB,
although the induction was not blocked with antisense oligonucleotides
for IkB. The right ®gure shows that NFkB was not detected when
incubated with antisense oligonucleotide for NFkB.
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inducing K6 and growth arrest by IFN-g. This should be further
examined carefully.
We examined if the growth arrest in HaCaT keratinocytes is
dependent on the activation of STAT1, as well as the induction of
K6. The growth arrest by IFN-g was reported both through c-myc
suppression by STAT1 phosporylation and through Raf-1 inde-
pendent of STAT1 (Ramana et al, 2000) in different cell types. Our
results showed that the inhibition of STAT1 phophorylation at
Tyr701 blocked the proliferation inhibitory effect by IFN-g as well
as the induction of K6, which indicated that both the inhibition of
proliferation and the induction of K6 needed STAT1 phosphoryl-
ation at Tyr701. These results demonstrated parallel mechanisms of
growth arrest and K6 induction by IFN-g.
IFN-g induced the release of IL-1a from keratinocytes, which
could also induce K6 (Komine et al, 2000). Therefore, we
investigated the effect of IL-1a released from keratinocytes. Our
results revealed that the amount of IL-1a released upon stimulation
with IFN-g was too small to induce K6 by itself, but the induction
of K6 was blocked by the incubation with neutralizing antibodies
against IL-1a. These results led to the speculation that the released
IL-1a did not induce K6 directly, but it might have a synergistic
effect on inducing K6 with IFN-g. NFkB is the possible
downstream signaling molecule by IL-1a stimulation to induce
K6. Therefore, we con®rmed the effect of NFkB on inducing K6
by IFN-g, by blocking the pathway of NFkB with antisense
oligonucleotides for NFkB. When we blocked the NFkB pathway
with antisense oligonucleotides for NFkB, the induction of K6 by
IFN-g was completely blocked. The inhibition of the STAT1
pathway with AxCAwtSTAT1 also blocked K6 induction by
IFN-g. These results indicated that the induction of K6 by IFN-g
needs both the NFkB and STAT1 pathways, which suggests their
synergistic interaction.
Our data showed that mRNAs of the K6 genes increased in
response to IFN-g treatment using ex vivo skin, and the K6
promoter activity in NHK increased by the incubation with IFN-g
dose-dependently, which indicated that the induction of K6 by
IFN-g occurred at the transcriptional level.
It is unknown if NFkB and STAT1 generate a synergistic effect
on the promoter of K6, or if these two pathways converge
independently of the promoter sequence. Several different mechan-
isms of synergistic effects between STAT1 and NFkB have been
reported (Ohmori et al, 1997; Pine, 1997). Synergistic induction of
IRF-1 by TNF-a and IFN-g has been shown, where a composite
IFN-g and TNF-a activation site, (GAS)/kB element in IRF-1
promoter seems responsible for the synergistic induction (Pine,
1997). On the other hand, it was also demonstrated that
cooperation between STAT-1 and NFkB occurs through inde-
pendent interactions between individual factors and DNA (Ohmori
et al, 1997). Protein±protein interaction between STAT-1 and
NFkB has not been demonstrated. As distinct putative binding sites
exist for both STAT-1 and NFkB on the K6 promoter, these
factors may independently bind to their binding sites. STAT1,
however, may not act by direct binding to the K6 promoter but
independently by interacting with other transcription factors such
as NFkB. Further investigation using an IFN-g response element in
the K6 promoter would be needed to clarify this question.
Our results showed clearly that IFN-g induced keratin K6
through a completely distinct pathway from K6 inductions by EGF
and TGF-a, i.e., the proliferative stimuli, or by TNF-a. This
induction by IFN-g is unique in that it requires not only STAT1
but also IL-1a and NFkB to stimulate the K6 induction. They also
suggest that a small amount of IL-1a, which cannot induce K6
alone, is secreted upon stimulation by IFN-g, and that the
induction of K6 occurs through the synergistic interaction of the
IFN-g/STAT1 and IL-1a/NFkB pathways.
This is the ®rst report that describes the K6 induction in
epidermal keratinocytes by IFN-g and indicates the probable signal
transduction pathway, which is distinct from other known
pathways that induce K6.
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